The forecast for the re-import of antibiotics to Canada from 2024 to 2028 shows a steady annual increase in value, starting from 53.52 thousand USD in 2024 to 54.42 thousand USD in 2028. This represents a yearly growth of around 0.43%, indicating a modest but consistent rise over this five-year period.
While these figures suggest moderate increments annually, the compound annual growth rate (CAGR) over these years points towards an average increase of 0.44% per year.
Future trends to watch include potential regulatory changes or public health developments that could affect import volumes. The antibiotic re-import market may face shifts due to evolving global healthcare policies and manufacturing innovations.
